Veeva Systems Inc. (VEEV)
Automate Your Wheel Strategy on VEEV
With Tiblio's Option Bot, you can configure your own wheel strategy including VEEV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol VEEV
- Rev/Share 17.5443
- Book/Share 38.1637
- PB 7.4469
- Debt/Equity 0.0124
- CurrentRatio 4.6049
- ROIC 0.0939
- MktCap 46441690400.0
- FreeCF/Share 7.396
- PFCF 38.5827
- PE 59.2486
- Debt/Assets 0.0099
- DivYield 0
- ROE 0.1374
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Reiterated | VEEV | Needham | -- | Buy | $270 | $300 | May 29, 2025 |
| Downgrade | VEEV | Goldman | Buy | Sell | $261 | $200 | Jan. 23, 2025 |
| Initiation | VEEV | Stephens | -- | Overweight | -- | $280 | Dec. 20, 2024 |
| Initiation | VEEV | Mizuho | -- | Outperform | -- | $275 | Dec. 4, 2024 |
| Initiation | VEEV | Exane BNP Paribas | -- | Outperform | -- | $286 | Oct. 8, 2024 |
| Reiterated | VEEV | Citigroup | -- | Buy | $256 | $273 | Aug. 27, 2024 |
News
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
VEEV leans on Vault R&D for growth as AI-native rivals rise, testing its edge in clinical and regulatory innovation.
Read More
Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Wall Street Analysts See Veeva (VEEV) as a Buy: Should You Invest?
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality
Published: July 30, 2025 by: PRNewsWire
Sentiment: Neutral
Veeva MedTech report reveals opportunity to move beyond manual processes for speed and compliance PLEASANTON, Calif. , July 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the 2025 Veeva Medtech Regulatory Affairs Benchmark, revealing that 50% of respondents lack full confidence in the completeness of their underlying data for global product registrations.
Read More
Veeva Systems Inc. (VEEV) Hits Fresh High: Is There Still Room to Run?
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
The Big 3: ANET, HSY, VEEV
Published: July 24, 2025 by: Schwab Network
Sentiment: Neutral
Dan Deming turns to two rising tech names and an ol' reliable in consumer staples for today's Big 3. He talks about the opportunity on weakness for Arista Networks (ANET), changes to note in Veeva Systems (VEEV), and Hershey's (HSY) earnings next week.
Read More
Veeva's Vault Vision: Can It Thrive After Parting With Salesforce?
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV stock climbs 36% YTD as it accelerates its shift off Salesforce, betting on Vault to power future growth in life sciences.
Read More
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Veeva vs. Salesforce: Which Life Sciences CRM Stock Is the Better Buy?
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.
Read More
Veeva Systems' Vault CRM Momentum Builds With Top Biopharma Adoptions
Published: July 16, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV sees rising Vault CRM adoption among top biopharma firms, driven by new features, fueling customer migration and growth.
Read More
Should You Invest in Veeva (VEEV) Based on Bullish Wall Street Views?
Published: July 15, 2025 by: Zacks Investment Research
Sentiment: Positive
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
Published: July 15, 2025 by: Zacks Investment Research
Sentiment: Positive
AI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
Read More
Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term
Published: July 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Veeva Expands Market Reach Through Targeted Strategic Partnerships
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.
Read More
VEEV Rises 29% in 3 Months: Should You Buy the Stock Now or Wait?
Published: July 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva Systems gains momentum as strong earnings, Vault CRM growth, and new AI tools reinforce its life sciences edge.
Read More
Veeva Systems: Growth Momentum Remains Strong
Published: July 08, 2025 by: Seeking Alpha
Sentiment: Positive
Veeva Systems is executing strongly, with accelerating growth in Vault CRM migrations and robust momentum across its portfolio, supporting my continued buy rating. Crossix is a standout growth driver, expanding rapidly and delivering measurable ROI for customers, making it a high-priority investment for pharma clients. Veeva's targeted AI strategy, embedding AI agents into core workflows, positions the company for deeper integration and future monetization opportunities.
Read More
VEEV Integrates GenAI in Vault Platform to Drive Workflow Automation
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva's new AI layer in Vault boosts automation and deepens pharma reliance, sharpening its edge in life sciences tech.
Read More
Here's Why Veeva Systems (VEEV) is a Strong Momentum Stock
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Veeva (VEEV) Up 0.8% Since Last Earnings Report: Can It Continue?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?
Read More
Is It Worth Investing in Veeva (VEEV) Based on Wall Street's Bullish Views?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
What Makes Veeva (VEEV) a New Strong Buy Stock
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Read More
Salesforce vs. Veeva: Which Cloud CRM Stock Is the Smarter Buy?
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
VEEV's niche focus and strong margins give it an edge over CRM despite its higher valuation and smaller scale.
Read More
Best Momentum Stock to Buy for June 25th
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
AEM, VEEV and EVR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 25, 2025.
Read More
Veeva Systems (VEEV) Just Overtook the 20-Day Moving Average
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
After reaching an important support level, Veeva Systems (VEEV) could be a good stock pick from a technical perspective. VEEV surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
Read More
Veeva and AWS Expand 10-Year Relationship
Published: June 25, 2025 by: Business Wire
Sentiment: Neutral
PLEASANTON, Calif. & SEATTLE--(BUSINESS WIRE)--Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and Veeva Systems (NYSE: VEEV), a leading provider of software, data, and business consulting for the life sciences industry, today announced an expansion of their long-standing collaboration. Veeva is using AWS as the cloud infrastructure for its Veeva Vault applications, including Veeva Vault CRM Suite. More than 50 Veeva Vault applications and specialized data offerings.
Read More
VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva Systems launches China Campaign Manager to boost pharma engagement with localized, compliant CRM-driven solutions.
Read More
Veeva Systems Inc. (VEEV) Hits Fresh High: Is There Still Room to Run?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Veeva (VEEV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Why Veeva Systems (VEEV) is a Top Momentum Stock for the Long-Term
Published: June 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
About Veeva Systems Inc. (VEEV)
- IPO Date 2013-10-16
- Website https://www.veeva.com
- Industry Medical - Healthcare Information Services
- CEO Peter P. Gassner
- Employees 7291